Vistagen Therapeutics, Inc.
fasedienol
social anxiety disorder
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on fasedienol for social anxiety disorder is expected Date TBD.
Primary source
· SEC 8-K
verified 14h ago
“If successful, we believe that PALISADE-4, together with the positive results from our PALISADE-2 Phase 3 trial and further evidence we plan to generate to support the clinical meaningfulness of the duration and magnitude of effect of fased”